Código QR (código de barras bidimensional)

Clinical benefit of treatment with eribulin mesylate for metastatic triple‐negative breast cancer: Long‐term outcomes of patients treated in the US community oncology setting

Abstract Introduction Real‐world data are critical to demonstrate the consistency of evidence and external generalizability of randomized controlled trials (RCTs). This study examined characteristics and outcomes of metastatic triple‐negative breast cancer (mTNBC) patients treated with eribulin mesy...

Fuld beskrivelse

Na minha lista:
Principais autores: Sarah S. Mougalian, Ronda Copher, Jonathan K. Kish, Lindsay McAllister, Zhixiao Wang, Mary Broscious, David Garofalo, Janna Radtchenko, Bruce A. Feinberg
Format: Artigo
Sprog:Inglês
Udgivet: Wiley 2018-09-01
Serier:Cancer Medicine
Fag:
eribulin
metastatic breast cancer
real‐world
survival
triple negative
Online adgang:https://doi.org/10.1002/cam4.1705
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker